Background Mounting evidence suggests a link between low zinc levels and depression. There is, however, little knowledge about zinc levels in older persons with other psychiatric diagnoses. Therefore, we explore the zinc status of elderly patients suffering from a wide range of psychiatric disorders. Methods Clinical data and blood samples for zinc analyzes were collected from 100 psychogeriatric patients over 64 of age. Psychiatric and cognitive symptoms were assessed using the Montgomery and Aasberg Depression Rating Scale, the Cornell Scale for Depression in Dementia, the Mini-Mental State Examination, the Clockdrawing Test, clinical interviews and a review of medical records. In addition, a diagnostic interview was conducted using the Mini International Neuropsychiatric Interview instrument. The prevalence of zinc deficiency in patients with depression was compared with the prevalence in patients without depression, and the prevalence in a control group of 882 older persons sampled from a population study. Results There was a significant difference in zinc deficiency prevalence between the control group (14.4%) and the patient group (41.0%) (χ2 = 44.81, df = 1, p<0.001). In a logistic model with relevant predictors, zinc deficiency was positively associated with gender and with serum albumin level. The prevalence of zinc deficiency in the patient group was significantly higher in patients without depression (i.e. with other diagnoses) than in patients with depression as a main diagnosis or comorbid depression (χ2 = 4.36, df = 1, p = 0.037). Conclusions Zinc deficiency is quite common among psychogeriatric patients and appears to be even more prominent in patients suffering from other psychiatric disorders than depression. Limitations This study does not provide a clear answer as to whether the observed differences represent a causal relationship between zinc deficiency and psychiatric symptoms. The blood sample collection time points varied in both the control group and the patient group. No data regarding zinc supplementation were collected.
References
[1]
Takeda A, Tamano H (2009) Insight into zinc signaling from dietary zinc deficiency. Brain Res Rev 62: 33–44.
[2]
Rink L, Gabriel P (2000) Zinc and the immune system. Proc Nutr Soc 59: 541–552.
[3]
Cope EC, Morris DR, Scrimgeour AG, Levenson CW (2012) Use of zinc as a treatment for traumatic brain injury in the rat: Effects on cognitive and behavioral outcomes. Neurorehabil Neural Repair 26: 907–913.
[4]
Marcellini F, Giuli C, Papa R, Gagliardi C, Dedoussis G, et al. (2006) Zinc status, psychological and nutritional assessment in old people recruited in five European countries: Zincage study. Biogerontology 7: 339–345.
[5]
Pepersack T, Rotsaert P, Benoit F, Willems D, Fuss M, et al. (2001) Prevalence of zinc deficiency and its clinical relevance among hospitalised elderly. Arch Gerontol Geriatr 33: 243–253.
[6]
Maes M, Vandoolaeghe E, Neels H, Demedts P, Wauters A, et al. (1997) Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry 42: 349–358.
[7]
Amani R, Saeidi S, Nazari Z, Nematpour S (2010) Correlation between dietary zinc intakes and its serum levels with depression scales in young female students. Biol Trace Elem Res 137: 150–158.
[8]
Siwek M, Dudek D, Schlegel-Zawadzka M, Morawska A, Piekoszewski W, et al. (2010) Serum zinc level in depressed patients during zinc supplementation of imipramine treatment. J Affect Disord 126: 447–452.
Whittle N, Lubec G, Singewald N (2009) Zinc deficiency induces enhanced depression-like behaviour and altered limbic activation reversed by antidepressant treatment in mice. Amino Acids 36: 147–158.
[11]
Mlyniec K, Nowak G (2012) Zinc deficiency induces behavioral alterations in the tail suspension test in mice. effect of antidepressants. Pharmacol Rep 64: 249–255.
[12]
Nowak G, Siwek M, Dudek D, Zieba A, Pilc A (2003) Effect of zinc supplementation on antidepressant therapy in unipolar depression: A preliminary placebo-controlled study. Pol J Pharmacol 55: 1143–1147.
[13]
Siwek M, Dudek D, Paul IA, Sowa-Kucma M, Zieba A, et al. (2009) Zinc supplementation augments efficacy of imipramine in treatment resistant patients: A double blind, placebo-controlled study. J Affect Disord 118: 187–95.
Shcherbatykh I, Carpenter DO (2007) The role of metals in the etiology of alzheimer's disease. J Alzheimers Dis 11: 191–205.
[16]
Haines A, Iliffe S, Morgan P, Dormandy T, Wood B (1991) Serum aluminium and zinc and other variables in patients with and without cognitive impairment in the community. Clin Chim Acta 198: 261–266.
[17]
Molina JA, Jimenez-Jimenez FJ, Aguilar MV, Meseguer I, Mateos-Vega CJ, et al. (1998) Cerebrospinal fluid levels of transition metals in patients with alzheimer's disease. J Neural Transm 105: 479–488.
[18]
Dong J, Robertson JD, Markesbery WR, Lovell MA (2008) Serum zinc in the progression of alzheimer's disease. J Alzheimers Dis 15: 443–450.
[19]
Chasapis CT, Loutsidou AC, Spiliopoulou CA, Stefanidou ME (2012) Zinc and human health: An update. Arch Toxicol 86: 521–534.
[20]
Stechmiller JK (2010) Understanding the role of nutrition and wound healing. Nutr Clin Pract 25: 61–68.
[21]
Barnett JB, Hamer DH, Meydani SN (2010) Low zinc status: A new risk factor for pneumonia in the elderly? Nutr Rev 68: 30–37.
[22]
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, et al. (1998) The mini-international neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 Suppl 2022–33.
[23]
Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382–389.
[24]
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–198.
[25]
Shulman KI (2000) Clock-drawing: Is it the ideal cognitive screening test? Int J Geriatr Psychiatry 15: 548–561.
[26]
Alexopoulos GS, Abrams RC, Young RC, Shamoian CA (1988) Cornell scale for depression in dementia. Biol Psychiatry 23: 271–284.
[27]
International Zinc Nutrition Consultative Group (IZiNCG), Brown KH, Rivera JA, Bhutta Z, Gibson RS, et al (2004) International zinc nutrition consultative group (IZiNCG) technical document #1. assessment of the risk of zinc deficiency in populations and options for its control. Food Nutr Bull 25: S99–203.
[28]
King JC (2011) Zinc: An essential but elusive nutrient. Am J Clin Nutr 94: 679S–84S.
[29]
Pedersen R, Hofmann B, Mangset M (2007) Patient autonomy and informed consent in clinical practice. Tidsskr Nor Laegeforen 127: 1644–1647.
[30]
Maes M, D′Haese PC, Scharpe S, D′Hondt P, Cosyns P, et al. (1994) Hypozincemia in depression. J Affect Disord 31: 135–140.
[31]
Wang CY, Wang T, Zheng W, Zhao BL, Danscher G, et al. (2010) Zinc overload enhances APP cleavage and abeta deposition in the alzheimer mouse brain. PLoS One 5: e15349.
[32]
Corona C, Pensalfini A, Frazzini V, Sensi SL (2011) New therapeutic targets in alzheimer's disease: Brain deregulation of calcium and zinc. Cell Death Dis 2: e176.
[33]
Shore D, Henkin RI, Nelson NR, Agarwal RP, Wyatt RJ (1984) Hair and serum copper, zinc, calcium, and magnesium concentrations in alzheimer-type dementia. J Am Geriatr Soc 32: 892–895.
[34]
Yanik M, Kocyigit A, Tutkun H, Vural H, Herken H (2004) Plasma manganese, selenium, zinc, copper, and iron concentrations in patients with schizophrenia. Biol Trace Elem Res 98: 109–117.
[35]
Rahman A, Azad MA, Hossain I, Qusar MM, Bari W, et al. (2009) Zinc, manganese, calcium, copper, and cadmium level in scalp hair samples of schizophrenic patients. Biol Trace Elem Res 127: 102–108.
[36]
Irmisch G, Schlaefke D, Richter J (2010) Zinc and fatty acids in depression. Neurochem Res 35: 1376–1383.
[37]
Narang RL, Gupta KR, Narang AP, Singh R (1991) Levels of copper and zinc in depression. Indian J Physiol Pharmacol 35: 272–274.
[38]
Mlyniec K, Davies CL, Budziszewska B, Opoka W, Reczynski W, et al. (2012) Time course of zinc deprivation-induced alterations of mice behavior in the forced swim test. Pharmacol Rep 64: 567–575.
[39]
Szewczyk B, Branski P, Wieronska JM, Palucha A, Pilc A, et al. (2002) Interaction of zinc with antidepressants in the forced swimming test in mice. Pol J Pharmacol 54: 681–685.
[40]
Rosa AO, Lin J, Calixto JB, Santos AR, Rodrigues AL (2003) Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. Behav Brain Res 144: 87–93.
[41]
Cieslik K, Klenk-Majewska B, Danilczuk Z, Wrobel A, Lupina T, et al. (2007) Influence of zinc supplementation on imipramine effect in a chronic unpredictable stress (CUS) model in rats. Pharmacol Rep 59: 46–52.
[42]
Stern RA, Robinson B, Thorner AR, Arruda JE, Prohaska ML, et al. (1996) A survey study of neuropsychiatric complaints in patients with graves' disease. J Neuropsychiatry Clin Neurosci 8: 181–185.
[43]
Chan AK, Duh QY, Katz MH, Siperstein AE, Clark OH (1995) Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study. Ann Surg 222: 402–12.
[44]
Gronli O, Wynn R (2013) Normocalcemic hyperparathyroidism and treatment resistant depression. Psychosomatics 54: 493–497.
[45]
Lachner C, Steinle NI, Regenold WT (2012) The neuropsychiatry of vitamin B12 deficiency in elderly patients. J Neuropsychiatry Clin Neurosci 24: 5–15.
[46]
Smart TG, Hosie AM, Miller PS (2004) Zn2+ ions: Modulators of excitatory and inhibitory synaptic activity. Neuroscientist 10: 432–442.
[47]
Szewczyk B, Kubera M, Nowak G (2011) The role of zinc in neurodegenerative inflammatory pathways in depression. Prog Neuropsychopharmacol Biol Psychiatry 35: 693–701.
[48]
Cichy A, Sowa-Kucma M, Legutko B, Pomierny-Chamiolo L, Siwek A, et al. (2009) Zinc-induced adaptive changes in NMDA/glutamatergic and serotonergic receptors. Pharmacol Rep 61: 1184–1191.
[49]
Prasad AS (2008) Zinc in human health: Effect of zinc on immune cells. Mol Med 14: 353–357.
[50]
Maes M, De Vos N, Demedts P, Wauters A, Neels H (1999) Lower serum zinc in major depression in relation to changes in serum acute phase proteins. J Affect Disord 56: 189–194.
[51]
Debnath M, Doyle KM, Langan C, McDonald C, Leonard B, et al. (2011) Recent advances in psychoneuroimmunology: Inflammation in psychiatric disorders. Translational Neuroscience 2: 121–137.
[52]
Yary T, Aazami S (2012) Dietary intake of zinc was inversely associated with depression. Biol Trace Elem Res 145: 286–290.
[53]
Maserejian NN, Hall SA, McKinlay JB (2012) Low dietary or supplemental zinc is associated with depression symptoms among women, but not men, in a population-based epidemiological survey. J Affect Disord 136: 781–788.
[54]
Jacka FN, Maes M, Pasco JA, Williams LJ, Berk M (2012) Nutrient intakes and the common mental disorders in women. J Affect Disord 141: 79–85.
[55]
Sen S, Duman R, Sanacora G (2008) Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implications. Biol Psychiatry 64: 527–532.
[56]
Gibson RS, Hess SY, Hotz C, Brown KH (2008) Indicators of zinc status at the population level: A review of the evidence. Br J Nutr 99 Suppl 3S14–23.
[57]
Lai J, Moxey A, Nowak G, Vashum K, Bailey K, et al. (2012) The efficacy of zinc supplementation in depression: Systematic review of randomised controlled trials. J Affect Disord 136: e31–9.
[58]
Baune BT, Thome J (2011) Translational research approach to biological and modifiable risk factors of psychosis and affective disorders. World J Biol Psychiatry 12 Suppl 128–34.
